Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P11+0+3-2+0
S42-0-2-1+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-07-20
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$131.09-6,48518,165-26%-$850,119
2017-07-17
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale$101.38-20014,701-1%-$20,276
D
2017-07-17
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale+OE$100.81-3,83014,901-20%-$386,103
2017-06-30
HPPIHedgepath Pharmaceuticals, Inc.Hedgepath, LLC10%S - Sale$0.00-2,500,00079,627,069-3%-$0
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$100.02-500346,5180%-$50,008
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$99.30-5,720336,678-2%-$568,011
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$99.07-9,264342,398-3%-$917,818
2017-07-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$98.92-9,516351,662-3%-$941,337
D
2017-07-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$126.18-3,00012,148-20%-$378,540
D
2017-07-03
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$126.20-1,82018,216-9%-$229,684
D
2017-07-03
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$35.21-1,98763,666-3%-$69,962
D
2017-06-30
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$129.74-59919,015-3%-$77,714
DM
2017-06-30
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.08-2,78532,600-8%-$75,430
DM
2017-07-03
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale+OE$58.32-6,87346,494-13%-$400,846
DM
2017-06-30
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale+OE$58.38-10,55573,380-13%-$616,159
D
2017-06-29
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.00-84632,600-3%-$22,842
DM
2017-06-27
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.13-5,05932,600-13%-$137,241
DM
2017-06-23
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.18-9,63532,600-23%-$261,918
D
2017-06-22
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.25-20932,600-1%-$5,696
D
2017-06-22
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale+OE$100.00-43,154371,518-10%-$4,315,400
D
2017-06-22
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$100.00-10,94863,566-15%-$1,094,800
DM
2017-06-20
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.38-2,15932,600-6%-$59,113
D
2017-06-20
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$125.00-9,88314,648-40%-$1,235,375
DM
2017-06-16
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.53-11,16832,600-26%-$307,401
DM
2017-06-14
NRCIANational Research CorpNunnelly John NDirS - Sale+OE$27.98-4,64032,600-12%-$129,820
2017-06-15
SRNESorrento Therapeutics, Inc.Ji HenryPres, CEOP - Purchase$1.81+29,0012,289,870+1%+$52,562
2017-06-15
SRNESorrento Therapeutics, Inc.Shah JaisimDirP - Purchase$1.79+10,002112,633+10%+$17,904
D
2017-06-12
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$116.60-16,75619,015-47%-$1,953,750
D
2017-06-08
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$95.00-94513,258-7%-$89,775
D
2017-06-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$132.50-3,00010,950-22%-$397,500
2017-05-31
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$84.01-5,154,93636,935,608-12%-$433,066,173
D
2017-06-01
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$130.00-1,82016,924-10%-$236,600
2017-05-31
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$131.80+5004,677+12%+$65,900
2017-05-31
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$84.01-1,087,7868,726,148-11%-$91,384,902
2017-05-30
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$18.46-5,000135,686-4%-$92,300
2017-05-31
QQuintiles Ims Holdings, Inc.Gillings Dennis B Ph DDirS - Sale$84.01-860,00010,123,929-8%-$72,248,600
2017-05-31
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$84.01-7,131,16517,038,426-30%-$599,089,172
2017-05-30
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$84.01-761,1435,453,659-12%-$63,943,623
D
2017-05-26
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$92.84-10,97663,566-15%-$1,019,022
D
2017-05-17
QQuintiles Ims Holdings, Inc.Greenberg Jack MDirS - Sale+OE$82.50-6,09227,930-18%-$502,590
2017-05-15
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$115.00+5004,177+14%+$57,500
D
2017-05-15
EXELExelixis, Inc.Feldbaum Carl BDirS - Sale+OE$21.58-32,98834,733-49%-$711,831
2017-05-12
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPres, CEOP - Purchase$4.00+2,80044,216+7%+$11,192
2017-05-12
CRLCharles River Laboratories International IncKochevar Deborah TurnerDirS - Sale$88.03-3008,486-3%-$26,408
D
2017-05-12
CRLCharles River Laboratories International IncKochevar Deborah TurnerDirS - Sale+OE$87.93-7,0708,786-45%-$621,640
2017-05-12
CRLCharles River Laboratories International IncMassaro GeorgeDirS - Sale$88.30-1,13014,701-7%-$99,784
DM
2017-05-08
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$21.87-211,300249,716-46%-$4,622,159-2
2017-05-08
INCYIncyte CorpHuber Reid MEVP, Chief Scientific OfficerS - Sale$119.21-8,57736,037-19%-$1,022,464-1
D
2017-05-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$121.70-3,00010,950-22%-$365,100-1
DM
2017-05-03
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$22.24-259,149249,668-51%-$5,762,838-10
D
2017-05-01
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.01-89,910184,690-33%-$2,068,519-2-3
D
2017-05-01
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale+OE$124.73-5,29612,653-30%-$660,5640-5
D
2017-05-01
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$124.73-1,82016,924-10%-$227,0090-5
D
2017-04-28
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$124.26-1,38919,015-7%-$172,5970-5
2017-04-28
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$124.26+5003,677+16%+$62,1300-5
D
2017-05-01
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale+OE$45.00-9,46774,468-11%-$426,015-6-1
D
2017-04-19
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%P - Purchase$2.00+550,0008,132,536+7%+$1,100,000+6+24
2017-04-19
SRNESorrento Therapeutics, Inc.Ji HenryPres, CEOP - Purchase$2.00+100,0002,260,869+5%+$200,000+3+15
D
2017-04-17
PRAHPra Health Sciences, Inc.Baddour LindaEVP, CFOS - Sale+OE$63.59-196,3930-100%-$12,488,631+1+1
D
2017-04-13
SRNESorrento Therapeutics, Inc.Abg Management Ltd10%P - Purchase$2.00+2,500,0007,582,536+49%+$5,000,000-15-4
2017-04-13
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$139.66+1,0003,177+46%+$139,6600-2
D
2017-04-07
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$137.88-32,00014,648-69%-$4,412,310+2-7-13
D
2017-04-10
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$140.18-4,04316,785-19%-$566,748+2-7-13
D
2017-04-10
INCYIncyte CorpGryska David WEVP, CFOS - Sale+OE$138.00-41,52819,015-69%-$5,730,864+2-7-13
2017-04-07
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$139.48+1,0002,177+85%+$139,480+2-7-13
D
2017-04-03
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5+6
2017-03-31
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPres, CEOP - Purchase$4.11+2,00041,416+5%+$8,229-3+1+9
D
2017-04-03
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$23.74-1,54357,298-3%-$36,631-1+1+38
D
2017-04-03
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale+OE$45.70-4,73348,317-9%-$216,298-1-2-8
D
2017-03-31
EXELExelixis, Inc.Wyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6+7
2017-03-28
CASCCascadian Therapeutics, Inc.Fyfe Gwen A.DirP - Purchase$4.12+1,6663,332+100%+$6,8570-9+3
D
2017-03-28
PRAHPra Health Sciences, Inc.Shannon ColinPres, CEOS - Sale+OE$64.00-50,0000-100%-$3,200,0000-1-2
D
2017-03-27
PRAHPra Health Sciences, Inc.Dockhorn David WEVP, CCOS - Sale+OE$62.00-85,1820-100%-$5,281,28400-2
2017-03-27
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
2017-03-24
SNMXSenomyx IncGray Mary AnnDirP - Purchase$1.00+10,00010,000New+$10,000+2+2-10
D
2017-03-22
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
M
2017-03-22
SNMXSenomyx IncPoyhonen JohnPres, CEOP - Purchase$0.98+50,000158,293+46%+$49,027+1+1-7
2017-03-20
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPres, CEOP - Purchase$3.93+1,00039,416+3%+$3,927+7+13+8
D
2017-03-20
EXELExelixis, Inc.Feldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-17
INCYIncyte CorpBrooke Paul ADirS - Sale+OE$147.75-20,000196,756-9%-$2,955,000-5-6-15
DM
2017-03-16
INCYIncyte CorpFriedman Paul ADirS - Sale+OE$148.72-50,000297,518-14%-$7,436,164-5-6-15
D
2017-03-15
EXELExelixis, Inc.Willsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-06
BHRTU.S. Stem Cell, Inc.Murphy William P JrDirP - Purchase$0.02+1,200,0001,564,039+330%+$24,000
D
2017-03-16
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$90.00-11,71763,566-16%-$1,054,530+1-2-2
2017-03-13
EXELExelixis, Inc.Cohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
2017-03-13
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$21.16-2,945343,170-1%-$62,3160+1+9
2017-03-13
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale$21.16-1,98354,153-4%-$41,9600+1+9
2017-03-13
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale$21.16-12,059907,418-1%-$255,1680+1+9
2017-03-13
EXASExact Sciences CorpArora ManeeshCOOS - Sale$21.16-5,574634,537-1%-$117,9460+1+9
2017-03-10
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale$89.71-3,19169,781-4%-$286,2540+1-3
2017-03-10
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale$89.44-7,307181,255-4%-$653,5400+1-3
D
2017-03-10
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale+OE$89.06-34,593188,562-16%-$3,080,9320+1-3
D
2017-03-10
EXELExelixis, Inc.Marchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-06
CRLCharles River Laboratories International IncBarbo William DCorporate EVP, CCOS - Sale$87.90-1,90020,924-8%-$167,014+1+10
D
2017-03-06
CRLCharles River Laboratories International IncBarbo William DCorporate EVP, CCOS - Sale+OE$87.78-12,54822,824-35%-$1,101,409+1+2+1

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top